TDF and Entekavir - Hepatitis B Reactivation

NCT06049602 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2023-09-22

No results posted yet for this study

Summary

This is a non-interventional retrospective multi-center study for the patients received Entekavir or TDF for Hepatitis B prophylaxis.

Conditions

  • Hepatitis B Reactivation

Sponsors & Collaborators

  • Viral Hepatitis Society

    lead OTHER

Principal Investigators

  • Ilker Kurkcu · Sentez CRO

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-15
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06049602 on ClinicalTrials.gov